(Bloomberg) -- The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the product. In a unanimous ruling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results